Yamamoto Masaaki, Yamasaki Makoto, Tanaka Koji, Miyazaki Yasuhiro, Makino Tomoki, Takahashi Tsuyoshi, Kurokawa Yukinori, Nakajima Kiyokazu, Takiguchi Shuji, Mori Masaki, Doki Yuichiro
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamadaoka, Suita, Osaka, 565-0871, Japan.
Surg Today. 2018 Feb;48(2):217-222. doi: 10.1007/s00595-017-1576-9. Epub 2017 Aug 23.
To create a new classification for the thoracic paraaortic lymph nodes (No. 112ao) of patients with esophageal squamous cell carcinoma (ESCC). Classification of these nodes in ESCC patients has been the focus of very few reports.
The subjects of this study were 27 patients with positive No. 112ao nodes on computed tomography (CT) images before treatment. We divided the No. 112ao nodes into No. 112aoA, located on the esophageal side as anterior No. 112ao nodes, and No. 112aoP, located on the opposite side of the esophagus as posterior No. 112ao nodes. We examined the association between No. 112aoA and No. 112aoP and clinicopathological factors. Recurrence-free survival (RFS) was compared between the No. 112aoA- and No. 112aoP-positive groups.
There were 12 patients in the No. 112aoA-positive group and 15 patients in the No. 112aoP-positive group. The No. 112aoP-positive group had significantly worse RFS than the No. 112aoA-positive group (p = 0.004). Cox multivariate analysis of RFS revealed that No. 112aoP positivity was an independent prognostic factor (p = 0.043).
Our new classification of No. 112ao nodes into No. 112aoA and No. 112aoP is useful clinically. No. 112aoP could correspond to the clinical N4 category of patients with ESCC.
为食管鳞状细胞癌(ESCC)患者的胸段主动脉旁淋巴结(第112ao组)创建一种新的分类方法。关于ESCC患者这些淋巴结的分类,相关报道极少。
本研究的对象为27例治疗前计算机断层扫描(CT)图像显示第112ao组淋巴结阳性的患者。我们将第112ao组淋巴结分为位于食管侧的第112aoA组(作为前第112ao组淋巴结)和位于食管对侧的第112aoP组(作为后第112ao组淋巴结)。我们研究了第112aoA组和第112aoP组与临床病理因素之间的关联。比较了第112aoA组和第112aoP组阳性患者的无复发生存期(RFS)。
第112aoA组阳性患者12例,第112aoP组阳性患者15例。第112aoP组阳性患者的RFS明显差于第112aoA组阳性患者(p = 0.004)。RFS的Cox多因素分析显示,第112aoP组阳性是独立的预后因素(p = 0.043)。
我们将第112ao组淋巴结新分为第112aoA组和第112aoP组在临床上是有用的。第112aoP组可能相当于ESCC患者的临床N4分类。